Predictors of appropriate implantable cardioverter defibrillator (ICD) therapy in primary prevention patients with ischemic and nonischemic cardiomyopathy

PACE - Pacing and Clinical Electrophysiology

Volumn 33, Issue 3, 2010, Pages 320-329

  Verma, Atul ^a   Sarak, Bradley ^a   Kaplan, Alexander J ^a   Oosthuizen, Richard ^a   Beardsall, Marianne ^a   Wulffhart, Zaev ^a   Higenbottam, Janet ^a   Khaykin, Yaariv ^a  

^a SOUTHLAKE REGIONAL HEALTH CENTRE   (Canada)

Author keywords

ICD therapy; Implantable cardioverter defibrillator; Primary prevention; Shock

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CONGESTIVE CARDIOMYOPATHY; DEFIBRILLATOR; ELECTROGRAPHY; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART LEFT VENTRICLE; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTENSION; IMPLANTATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PREDICTOR VARIABLE; PRIMARY PREVENTION; PROPORTIONAL HAZARDS MODEL; QRS COMPLEX; UNIVARIATE ANALYSIS;

AGED; CARDIOMYOPATHIES; CHI-SQUARE DISTRIBUTION; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PRIMARY PREVENTION; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 77649243092     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2009.02566.x     Document Type: Article

References (36)

1. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 1997 337 : 1576 1583.
2. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004 350 : 2151 2158.
3. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002 346 : 877 883.
4. Anvari A, Gottsauner-Wolf M, Turel Z, Stix G, Podesser B, Mayer C, Schuster E, et al. Predictors of outcome in patients with implantable cardioverter defibrillators. Cardiology 1998 90 : 180 186.
5. Dolack GL. Clinical predictors of implantable cardioverter-defibrillator shocks (results of the CASCADE trial). Cardiac arrest in Seattle, conventional versus amiodarone drug evaluation. Am J Cardiol 1994 73 : 237 241.
6. Grimm W, Flores BT, Marchlinski FE. Shock occurrence and survival in 241 patients with implantable cardioverter-defibrillator therapy. Circulation 1993 87 : 1880 1888. (Pubitemid 23165630)
7. Levine JH, Mellits ED, Baumgardner RA, Veltri EP, Mower M, Grunwald L, Guarnieri T, et al. Predictors of first discharge and subsequent survival in patients with automatic implantable cardioverter-defibrillators. Circulation 1991 84 : 558 566.
8. Rankovic V, Karha J, Passman R, Kadish AH, Goldberger JJ. Predictors of appropriate implantable cardioverter-defibrillator therapy in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 2002 89 : 1072 1076.
9. Whang W, Mittleman MA, Rich DQ, Wang PJ, Ruskin JN, Tofler GH, Muller JE, et al. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: Results from the Triggers Of Ventricular Arrhythmias (TOVA) study. Circulation 2004 109 : 1386 1391.
10. Reiter MJ, Fain ES, Senelly KM, Robertson AD. Predictors of device activation for ventricular arrhythmias and survival in patients with implantable pacemakers/defibrillators. CADENCE Investigators. Pacing Clin Electrophysiol 1994 17 : 1487 1498.
11. Singh JP, Hall WJ, McNitt S, Wang H, Daubert JP, Zareba W, Ruskin JN, et al. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation. J Am Coll Cardiol 2005 46 : 1712 1720.
12. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005 352 : 225 237.
13. Sanchez JM, Greenberg SL, Chen J, Gleva MJ, Lindsay BD, Smith TW, Faddis MN. Smokers are at markedly increased risk of appropriate defibrillator shocks in a primary prevention population. Heart Rhythm 2006 3 : 443 449.
14. Lampert R, McPherson CA, Clancy JF, Caulin-Glaser TL, Rosenfeld LE, Batsford WP. Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter-defibrillators. J Am Coll Cardiol 2004 43 : 2293 2299.
15. Buxton AE, Sweeney MO, Wathen MS, Josephson ME, Otterness MF, Hogan-Miller E, Stark AJ, et al. QRS duration does not predict occurrence of ventricular tacharrhythmias in patients with implanted cardioverter- defibrillators. J Am Coll Cardiol 2005 46 : 310 316.
16. Vyas AK, Guo H, Moss AJ, Olshansky B, McNitt SA, Hall WJ, Zareba W, et al. Reduction in ventricular tacharrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol 2006 47 : 769 773.
17. Coleman CI, Kluger J, Bhavnani S, Clyne C, Yarlagadda R, Guertin D, White CM. Association between statin use and mortality in patients with implantable cardioverter defibrillators and left ventricular systolic dysfunction. Heart Rhythm 2008 5 : 507 510.
18. Pietrasik G, Goldenberg I, McNitt S, Moss AJ, Zareba W. Obesity as a risk factor for sustained ventricular tacharrhythmias in MADIT-II patients. J Cardiovasc Electrophysiol 2007 18 : 181 184.
19. Goldenberg I, Moss AJ, McNitt S, Zareba W, Daubert JP, Hall WJ, Andrews ML, Multicenter Automatic Defibrillator Implantation Trial-II Investigators. Cigarette smoking and the risk of supraventricular and ventricular tacharrhythmias in high-risk cardiac patients with implantable cardioverter defibrillators. J Cardiovasc Electrophysiol 2006 17 : 931 936.
20. Robin J, Weinberg K, Tiongson J, Carnethon M, Reddy M, Ciaccio C, Quadrini M, et al. Renal disease as a risk factor for appropriate therapies and mortality in implantable cardioverter-defibrillator recipients. Heart Rhythm 2006 3 : 1196 1201.
21. Gillis AM, Sheldon RS, Wyse DG, Duff HJ, Cassidy MR, Mitchell LB. Clinical and electrophysiologic predictors of ventricular tachyarrhythmia recurrence in patients with implantable cardioverter defibrillators. J Cardiovasc Electrophysiol 2003 14 : 492 498.
22. Raitt MH, Klein RC, Wyse DG, Wilkoff BL, Beckman K, Epstein AE, Coromilas J, et al. Comparison of arrhythmia recurrence in patients presenting with ventricular fibrillation versus ventricular tachycardia in the antiarrhythmics versus implantable defibrillators (AVID) trial. Am J Cardiol 2003 91 : 812 816.
23. Swerdlow CD. Supraventricular tachycardia-ventricular tachycardia discrimination algorithms in implantable cardioverter defibrillators: State-of-the-art review. J Cardiovasc Electrophysiol 2001 12 : 606 612.
24. Wathen MS, Sweeney MO, DeGroot PJ, Stark AJ, Koehler JL, Chisner MB, Machado C, et al. Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease. Circulation 2001 104 : 796 801.
25. Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO, Canby RC, et al. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) Trial results. Circulation 2004 110 : 2591 2596.
26. Alsheikh-Ali AA, Homer M, Maddukuri PV, Kalsmith B, Estes NA 3rd., Link MS. Time-dependence of appropriate implantable defibrillator therapy in patients with ischemic cardiomyopathy. J Cardiovasc Electrophysiol 2008 19 : 784 789.
27. Epstein AE, Dimarco JP, Ellenbogen KA, Estes NA 3rd., Freedman RA, Gettes LS, Gillinov AM, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: Executive summary. Heart Rhythm 2008 5 : 934 955.
28. Konstantino Y, Kusniec J, Reshef T, David-Zadeh O, Mazur A, Strasberg B, Battler A, et al. Inflammatory biomarkers are not predictive of intermediate-term risk for ventricular tacharrhythmias in stable CHF patients. Clin Cardiol 2007 30 : 408 413.
29. Rienstra M, Smit MD, Nieuwland W, Tan ES, Wiesfeld AC, Anthonio RL, Van Den Berg MP, et al. Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator. Am Heart J 2007 153 : 120 126.
30. Berenbom LP, Weiford BC, Vacek JL, Emert MP, Hall WJ, Andrews ML, McNitt S, et al. Differences in outcomes between patients treated with single- versus dual-chamber implantable cardioverter defibrillators: A study of the Multicenter Automatic Defibrillator Implantation Trial II. Ann Noninvasive Electrocardiol 2005 10 : 429 435.
31. Goldenberg I, Vyas AK, Hall WJ, Moss AJ, Wang H, He H, Zareba W, et al. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol 2008 51 : 288 296.
32. Buxton AE, Lee KL, DiCarlo L, Gold MR, Greer GS, Prystowsky EN, O'Toole MF, et al., Multicenter Unsustained Tachycardia Trial Investigators. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. N Engl J Med 2000 Jun 29 342 : 1937 1945.
33. Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, Fain ES, Thorpe K, et al, Optimal Pharmacological Therapy in Cardioverter Defibrillator Patients (OPTIC) Investigators. Comparison of β-blockers, amiodarone plus β-blockers or sotalol for prevention of shocks from implantable cardioverter defibrillators: The OPTIC study: A randomized trial. JAMA 2006 295 : 165 171.
34. Brodine WN, Tung RT, Lee JK, Hockstad ES, Moss AJ, Zareba W, Hall WJ, et al. Effects of β-blockers on implantable cardioverter defibrillator therapy and survival in the patients with ischemic cardiomyopathy (from the multicenter automatic defibrillator implantation trial-II). Am J Cardiol 2005 96 : 691 695.
35. Saxon LA, Bristow MR, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, et al. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) Trial. Circulation 2006 114 : 2766 2772.
36. Daubert JP, Zareba W, Hall WJ, Schuger C, Corsello A, Leon AR, Andrews ML, et al. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in multicenter automatic defibrillator implantation trial (MADIT) II patients. J Am Coll Cardiol 2006 47 : 98 107.